# Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 Patients

> **NCT00680173** · PHASE4 · COMPLETED · sponsor: **Kaohsiung Medical University Chung-Ho Memorial Hospital** · enrollment: 30 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** pegylated interferon alpha 2a and plus ribavirin

## Key facts

- **NCT ID:** NCT00680173
- **Lead sponsor:** Kaohsiung Medical University Chung-Ho Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00680173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00680173, "Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 Patients". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00680173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*